Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan
about
Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial EvidenceEffectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic PatientsA double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study.Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE StudyFasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
P2860
Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Experience with DPP-4 inhibito ...... iabetes fasting during Ramadan
@en
Experience with DPP-4 inhibito ...... abetes fasting during Ramadan.
@nl
type
label
Experience with DPP-4 inhibito ...... iabetes fasting during Ramadan
@en
Experience with DPP-4 inhibito ...... abetes fasting during Ramadan.
@nl
prefLabel
Experience with DPP-4 inhibito ...... iabetes fasting during Ramadan
@en
Experience with DPP-4 inhibito ...... abetes fasting during Ramadan.
@nl
P2093
P2860
P921
P356
P1476
Experience with DPP-4 inhibito ...... iabetes fasting during Ramadan
@en
P2093
Anja Schweizer
Serge Halimi
Sylvie Dejager
P2860
P356
10.2147/VHRM.S54585
P407
P5008
P577
2013-12-24T00:00:00Z